MetLife Investment Management’s Tectonic Therapeutic TECX Stock Holding History

MetLife Investment Management’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$208K	Hold	6,724	–	–	﹤0.01%	2207
2025 Q4	$140K	Hold	6,724	–	–	﹤0.01%	2447
2025 Q3	$106K	Hold	6,724	–	–	﹤0.01%	2628
2025 Q2	$134K	Buy	+6,724	New	+$136K	﹤0.01%	2395
2021 Q4	–	Sell	-1,221	Closed	-$81.8K	–	2562
2021 Q3	$81.8K	Buy	1,221 +1,096	+877%	+$89.9K	﹤0.01%	2502
2021 Q2	$13.4K	Sell	125 -1,029	-89%	-$122K	﹤0.01%	2433
2021 Q1	$176K	Sell	1,154 -45	-4%	-$7.32K	﹤0.01%	2124
2020 Q4	$201K	Hold	1,199	–	–	﹤0.01%	1982
2020 Q3	$187K	Hold	1,199	–	–	﹤0.01%	1901
2020 Q2	$251K	Buy	1,199 +286	+31%	+$58.9K	﹤0.01%	1764
2020 Q1	$170K	Buy	913 +203	+29%	+$47.8K	﹤0.01%	1787
2019 Q4	$171K	Hold	710	–	–	﹤0.01%	2060
2019 Q3	$120K	Hold	710	–	–	﹤0.01%	2226
2019 Q2	$138K	Buy	+710	New	+$153K	﹤0.01%	2229
2018 Q4	–	Sell	-421	Closed	-$262K	–	2597
2018 Q3	$262K	Buy	+421	New	+$187K	﹤0.01%	1935

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

MetLife Investment Management's TECX Position: Q1 2026 in Review

MetLife Investment Management held its Tectonic Therapeutic (TECX) position steady in Q1 2026 at 6,724 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2207.

MetLife Investment Management first reported a position in TECX in Q3 2018 and has held it in 15 quarters since. The position peaked at $262K in Q3 2018. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

MetLife Investment Management held 6,724 shares of Tectonic Therapeutic worth $208K as of Q1 2026.
MetLife Investment Management left its Tectonic Therapeutic share count unchanged in Q1 2026.
Tectonic Therapeutic made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2207 holding.
MetLife Investment Management first reported a position in Tectonic Therapeutic in Q3 2018 and has held it in 15 quarters since.
MetLife Investment Management's Tectonic Therapeutic position peaked at $262K in Q3 2018.
111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.